Effervescent Bisphosphonate Formulation Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional effervescent bisphosphonate formulations experience degradation due to reactions between citrate and polyols, leading to unknown and uncharacterized degradation products, which are difficult to detect using conventional chromatographic methods, and result in instability and reduced bioequivalence.
Innovation Solution
A storage-stable effervescent tablet composition is developed using a fluidized bed granulation process, excluding polyol binders and lubricants, with micronized sodium alendronate and an effervescing system containing citric acid and mono-sodium citrate, achieving rapid disintegration and complete solubilization in water without manual stirring, and maintaining stability at elevated temperatures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional effervescent formulations use polyols and citrate together, then effervescent characteristics are achieved, but degradation products form during storage
Solution Approach 1:
The patent removes polyols from the formulation entirely, extracting the problematic component that causes degradation when combined with citrate. The effervescent characteristics are maintained through alternative excipients that do not undergo esterification reactions with citrate, thereby eliminating degradation product formation while preserving the desired effervescent behavior.
Solution Approach 2:
The patent changes the chemical composition parameters of the formulation by substituting polyol binders and lubricants with alternative excipients that are chemically inert toward citrate. This parameter change prevents the esterification reaction that occurs between polyols and citrate at elevated temperatures, thereby stabilizing the formulation during storage while maintaining effervescent properties.
2Productivity
If effervescent formulations are designed for rapid dissolution, then patient compliance improves, but degradation products form during storage
Solution Approach 1:
The patent extracts polyols from the formulation, removing the source of degradation products. The rapid dissolution characteristics are achieved through alternative excipient selection and formulation design that does not rely on polyol-citrate interactions, thereby maintaining both fast dissolution and storage stability simultaneously.
Solution Approach 2:
The patent employs a composite excipient system that combines alternative binders, disintegrants, and lubricants none of which contain polyols. This composite material approach achieves the desired rapid dissolution profile through synergistic interactions among the alternative excipients while preventing degradation product formation during storage.
3Reliability
If ion chromatographic methods are used to detect degradation products, then formulation stability can be evaluated, but detection requires specialized equipment and low wavelength UV light
Solution Approach 1:
The patent converts the potential harm of requiring specialized analytical equipment into a benefit by demonstrating that eliminating polyols from the formulation makes degradation product detection unnecessary or simplifies it. Without polyols, the esterification reactions that produce undetectable degradation products do not occur, thereby simplifying stability evaluation while maintaining reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution minimizes degradation product formation, ensures rapid and complete dissolution of alendronate, and maintains stability over time, addressing the issues of esophageal irritation and bioequivalence concerns, while maintaining consumer acceptability and tablet performance characteristics.
Implementation Method 1
an effervescing system containing citric acid and mono-sodium citrate
Implementation Method 2
achieving rapid disintegration and complete solubilization in water without manual stirring
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
A stable effervescent tablet, granule or powder composition free from excipients that may react with an effervescing organic acid component, comprising. an effective amount of a bisphosphonate bone resorption inhibitor, an effervescing organic acid component, an effervescing base component; wherein said composition is free of polyol binders and tableting lubricants; has a loss on drying of 0.25% (m/m) or less; has a complete disintegration time of no more than 180 seconds when placed in 3 to 8 fluid ounces of water at between 5 - 20 °C; and said bisphosphonate is incorporated as a micronized particle or by spray drying and is completely solubdised in water within 2 minutes without stirring.